28 results
8-K
EX-10.1
XLO
Xilio Therapeutics Inc
3 Jan 24
Departure of Directors or Certain Officers
4:05pm
is an Eligible Participant on the date of the Participant’s death or disability (within the meaning of Section 409A(a)(2)(C) of the Internal Revenue Code … of 1986, as amended), all RSUs subject to this agreement shall immediately vest in full effective as of the date of such death or disability.]
Number
8-K
EX-10.1
XLO
Xilio Therapeutics Inc
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
under, all employee health, disability, insurance, fringe, welfare benefit and retirement plans, arrangements, practices and programs the Company … of any of the following:
(a)Upon the death or Disability of the Executive. As used in this Agreement, the term “Disability” shall mean a physical
8-K
EX-10.1
ldh35s7 3nlz1g2
3 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
xf54s2ro4
16 Jun 22
Departure of Directors or Certain Officers
7:45am
DEF 14A
m64zsxdr0 80
26 Apr 22
Definitive proxy
4:05pm
10-K
EX-10.20
afkroouxt99jgm4ctbr
1 Mar 22
Annual report
4:07pm
S-1/A
EX-10.6
6xxd2844x6wz21mr276s
18 Oct 21
IPO registration (amended)
6:04am
S-1/A
EX-10.7
nn3m m5dg4t7gihyuazu
18 Oct 21
IPO registration (amended)
6:04am
S-1/A
EX-10.5
drddkv7ip6zx9w09ckvf
18 Oct 21
IPO registration (amended)
6:04am
S-1
EX-10.2
hg5aysjsaahsbn0yl
1 Oct 21
IPO registration
4:49pm
S-1
EX-10.10
vmwvhg8x4h 83
1 Oct 21
IPO registration
4:49pm
S-1
EX-10.17
65yn ui7f3l
1 Oct 21
IPO registration
4:49pm
S-1
EX-10.3
gvye06 1hcf
1 Oct 21
IPO registration
4:49pm